These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 29948941)

  • 1. Multifaceted Regulation of ALDH1A1 by Cdk5 in Alzheimer's Disease Pathogenesis.
    Nikhil K; Viccaro K; Shah K
    Mol Neurobiol; 2019 Feb; 56(2):1366-1390. PubMed ID: 29948941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cdk5-Foxo3 axis: initially neuroprotective, eventually neurodegenerative in Alzheimer's disease models.
    Shi C; Viccaro K; Lee HG; Shah K
    J Cell Sci; 2016 May; 129(9):1815-1830. PubMed ID: 28157684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deregulated Cdk5 promotes oxidative stress and mitochondrial dysfunction.
    Sun KH; de Pablo Y; Vincent F; Shah K
    J Neurochem; 2008 Oct; 107(1):265-78. PubMed ID: 18691386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Cdk5-Mcl-1 axis promotes mitochondrial dysfunction and neurodegeneration in a model of Alzheimer's disease.
    Nikhil K; Shah K
    J Cell Sci; 2017 Sep; 130(18):3023-3039. PubMed ID: 28751497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutathione-S-transferase P1 is a critical regulator of Cdk5 kinase activity.
    Sun KH; Chang KH; Clawson S; Ghosh S; Mirzaei H; Regnier F; Shah K
    J Neurochem; 2011 Sep; 118(5):902-14. PubMed ID: 21668448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unveiling Potential Neurotoxic Mechansisms: Pb-Induced Activation of CDK5-p25 Signaling Axis in Alzheimer's Disease Development, Emphasizing CDK5 Inhibition and Formation of Toxic p25 Species.
    Lokesh M; Bandaru LJM; Rajanna A; Rao JS; Challa S
    Mol Neurobiol; 2024 May; 61(5):3090-3103. PubMed ID: 37968421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cdk5 is a major regulator of p38 cascade: relevance to neurotoxicity in Alzheimer's disease.
    Chang KH; de Pablo Y; Lee HP; Lee HG; Smith MA; Shah K
    J Neurochem; 2010 Jun; 113(5):1221-9. PubMed ID: 20345761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid-ß promotes neurotoxicity by Cdk5-induced p53 stabilization.
    Lapresa R; Agulla J; Sánchez-Morán I; Zamarreño R; Prieto E; Bolaños JP; Almeida A
    Neuropharmacology; 2019 Mar; 146():19-27. PubMed ID: 30452955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct and indirect roles of cyclin-dependent kinase 5 as an upstream regulator in the c-Jun NH2-terminal kinase cascade: relevance to neurotoxic insults in Alzheimer's disease.
    Sun KH; Lee HG; Smith MA; Shah K
    Mol Biol Cell; 2009 Nov; 20(21):4611-9. PubMed ID: 19776350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of mitofusin 2 links beta-amyloid-mediated mitochondrial fragmentation and Cdk5-induced oxidative stress in neuron cells.
    Park J; Choi H; Min JS; Kim B; Lee SR; Yun JW; Choi MS; Chang KT; Lee DS
    J Neurochem; 2015 Mar; 132(6):687-702. PubMed ID: 25359615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of cyclin-dependent kinase 5 in the neurodegenerative process triggered by amyloid-Beta and prion peptides: implications for Alzheimer's disease and prion-related encephalopathies.
    Lopes JP; Oliveira CR; Agostinho P
    Cell Mol Neurobiol; 2007 Nov; 27(7):943-57. PubMed ID: 17965932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deregulated Cdk5 triggers aberrant activation of cell cycle kinases and phosphatases inducing neuronal death.
    Chang KH; Vincent F; Shah K
    J Cell Sci; 2012 Nov; 125(Pt 21):5124-37. PubMed ID: 22899714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear envelope dispersion triggered by deregulated Cdk5 precedes neuronal death.
    Chang KH; Multani PS; Sun KH; Vincent F; de Pablo Y; Ghosh S; Gupta R; Lee HP; Lee HG; Smith MA; Shah K
    Mol Biol Cell; 2011 May; 22(9):1452-62. PubMed ID: 21389115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurodegeneration in an Abeta-induced model of Alzheimer's disease: the role of Cdk5.
    Lopes JP; Oliveira CR; Agostinho P
    Aging Cell; 2010 Feb; 9(1):64-77. PubMed ID: 19895631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ginsenoside Rg1 reduces β‑amyloid levels by inhibiting CDΚ5‑induced PPARγ phosphorylation in a neuron model of Alzheimer's disease.
    Quan Q; Li X; Feng J; Hou J; Li M; Zhang B
    Mol Med Rep; 2020 Oct; 22(4):3277-3288. PubMed ID: 32945455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cdk5 increases MARK4 activity and augments pathological tau accumulation and toxicity through tau phosphorylation at Ser262.
    Saito T; Oba T; Shimizu S; Asada A; Iijima KM; Ando K
    Hum Mol Genet; 2019 Sep; 28(18):3062-3071. PubMed ID: 31174206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of Cdk5-mediated Drp1 phosphorylation in Aβ
    Guo MY; Shang L; Hu YY; Jiang LP; Wan YY; Zhou QQ; Zhang K; Liao HF; Yi JL; Han XJ
    J Cell Biochem; 2018 Jun; 119(6):4815-4825. PubMed ID: 29345339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cdk5 protein inhibition and Aβ42 increase BACE1 protein level in primary neurons by a post-transcriptional mechanism: implications of CDK5 as a therapeutic target for Alzheimer disease.
    Sadleir KR; Vassar R
    J Biol Chem; 2012 Mar; 287(10):7224-35. PubMed ID: 22223639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of aberrant CDK5 signaling rescues impaired neurogenesis in models of Alzheimer's disease.
    Crews L; Patrick C; Adame A; Rockenstein E; Masliah E
    Cell Death Dis; 2011 Feb; 2(2):e120. PubMed ID: 21368891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective effect of TNFalpha against the beta-amyloid neurotoxicity mediated by CDK5 kinase.
    Orellana DI; Quintanilla RA; Maccioni RB
    Biochim Biophys Acta; 2007 Feb; 1773(2):254-63. PubMed ID: 17150266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.